You have 9 free searches left this month | for more free features.

Multiple Sclerosis, Chronic Progressive

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))

Recruiting
  • Progressive Multiple Sclerosis
  • Placebo
  • Masitinib (4.5)
  • Lille, France
  • +1 more
Jul 1, 2022

Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral

Recruiting
  • Secondary Progressive Multiple Sclerosis
  • Primary Progressive Multiple Sclerosis
  • Metformin 500 Mg Oral Tablet, up to 4 tablets a day
  • Placebo oral tablet identical to metformin, up to 4 tablets a day
  • Los Angeles, California
    University of California, Los Angeles
May 2, 2022

Progressive Multiple Sclerosis Trial in Berlin (GZ402668, Placebo, Acyclovir)

Completed
  • Progressive Multiple Sclerosis
  • Berlin, Germany
    Investigational Site Number 276001
Apr 22, 2022

Visual Processing Speed and Objective Analysis of Ocular

Enrolling by invitation
  • Multiple Sclerosis
  • +3 more
  • Eye tracking
  • +3 more
  • Valladolid, Spain
    IOBA - Universidad de Valladolid
Jan 20, 2023

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in San Francisco

Recruiting
  • Multiple Sclerosis
  • +2 more
  • N-acetyl cysteine
  • Placebo
  • San Francisco, California
    University of California, San Francisco
Mar 22, 2022

Gray Matter Demyelination in Primary Progressive MS at 7T

Recruiting
  • Primary Progressive Multiple Sclerosis
    • Hvidovre, Denmark
      Danish Research Centre for Magnetic Resonance
    Jun 5, 2022

    Progressive Multiple Sclerosis, Fatigue Trial in San Francisco (N-acetyl cysteine, Placebo)

    Completed
    • Progressive Multiple Sclerosis
    • Fatigue
    • N-acetyl cysteine
    • Placebo
    • San Francisco, California
      University of California San Francisco
    Sep 6, 2022

    Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive Trial in Porto Alegre

    Not yet recruiting
    • Multiple Sclerosis, Chronic Progressive
    • +3 more
    • Nordic Walking (NWG)
    • +2 more
    • Porto Alegre, Rio Grande Do Sul, Brazil
      Universidade Federal do Rio Grande do Sul
    May 17, 2022

    Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City

    Recruiting
    • Secondary Progressive Multiple Sclerosis
    • +2 more
    • Ferumoxytol infusion
    • +2 more
    • Salt Lake City, Utah
      University of Utah Health Imaging and Neurosciences Center
    Jun 22, 2022

    Secondary Progressive Multiple Sclerosis (SPMS) Trial in Tel Aviv (SCM-010)

    Not yet recruiting
    • Secondary Progressive Multiple Sclerosis (SPMS)
    • SCM-010
    • Tel Aviv, Israel
      Tel Aviv Medical Center
    Oct 26, 2022

    Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Marseille, Rennes (Magnetic

    Recruiting
    • Multiple Sclerosis, Primary Progressive
    • Multiple Sclerosis, Secondary Progressive
    • Magnetic Resonance Imaging
    • +3 more
    • Marseille, France
    • +1 more
    Jan 14, 2022

    Upper Extremity Function in Multiple Sclerosis Advanced

    Active, not recruiting
    • Multiple Sclerosis
    • +7 more
    • Tampa, Florida
      Carol and Frank Morsani Center for Advanced Healthcare
    Nov 2, 2022

    Multiple Sclerosis, Progressive Multiple Sclerosis Trial in Norway (MSCs, Saline)

    Recruiting
    • Multiple Sclerosis
    • Progressive Multiple Sclerosis
    • Tromsø, Troms Og Finnmark, Norway
    • +3 more
    Jul 28, 2022

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial

    Active, not recruiting
    • Secondary Progressive Multiple Sclerosis
    • +2 more
    • Minneapolis, Minnesota
    • +2 more
    Mar 29, 2022

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab

    Withdrawn
    • Primary Progressive Multiple Sclerosis
    • +2 more
    • Intranasal Foralumab Solution
    • Placebo
    • (no location specified)
    Feb 14, 2022

    Multiple Sclerosis, Secondary Progressive Trial in Calgary (Hydroxychloroquine Pill, Indapamide Pill)

    Recruiting
    • Multiple Sclerosis, Secondary Progressive
    • Hydroxychloroquine Pill
    • Indapamide Pill
    • Calgary, Alberta, Canada
      Foothills Medical Centre
    May 16, 2022

    Measuring Active Microglia in Progressive Multiple Sclerosis

    Completed
    • Secondary Progressive Multiple Sclerosis
    • [C11]PK-1195 PET scan
    • New York, New York
      Weill Cornell Medical College
    Jan 14, 2022

    Multiple Sclerosis Trial in Canada, United States (Lipoic acid, Placebo)

    Active, not recruiting
    • Multiple Sclerosis
    • Lipoic acid
    • Placebo
    • Birmingham, Alabama
    • +10 more
    Jan 31, 2023

    Multiple Sclerosis, Primary Progressive Trial in Bordeaux, Limoges, Poitiers (Clinical assessment, Ecological evaluation,

    Recruiting
    • Multiple Sclerosis, Primary Progressive
    • Clinical assessment
    • +4 more
    • Bordeaux, France
    • +2 more
    Mar 31, 2022

    Primary Progressive Multiple Sclerosis, Exercise, Cardiorespiratory Fitness Trial in Valens (HIIT, MCT)

    Recruiting
    • Primary Progressive Multiple Sclerosis
    • +2 more
    • HIIT
    • MCT
    • Valens, Sankt Gallen, Switzerland
      Klinik Valens, Valens rehabilitation clinic
    Jun 9, 2022

    Primary Progressive Multiple Sclerosis Trial in Durham (DUOC-01)

    Recruiting
    • Primary Progressive Multiple Sclerosis
    • DUOC-01
    • Durham, North Carolina
      Duke University Medical Center
    Jan 25, 2022

    Progressive Multiple Sclerosis Trial in Indianapolis (G-EO System (Reha Technology AG: Olten, Switzerland), Conventional

    Completed
    • Progressive Multiple Sclerosis
    • G-EO System (Reha Technology AG: Olten, Switzerland)
    • Conventional Physical Therapy
    • Indianapolis, Indiana
      Neurorehabilitation and Robotics at IU Health Neuroscience Cente
    Jan 20, 2022

    Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Caen (Cognitive rehabilitation,

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • Secondary Progressive Multiple Sclerosis
    • Cognitive rehabilitation
    • Standard Psychological care
    • Caen, Calvados, France
      University Hospital of Caen
    Mar 8, 2022

    Secondary Progressive Multiple Sclerosis Trial in Germany (BAF312, Baseline disease modifying therapies (DMTs))

    Active, not recruiting
    • Secondary Progressive Multiple Sclerosis
    • BAF312
    • Baseline disease modifying therapies (DMTs)
    • Mittweida, Sachsen, Germany
    • +9 more
    Aug 9, 2022

    Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • +2 more
    • Ixazomib (NINLARO®) capsules / Matching placebo capsules
    • London, Greater London, United Kingdom
      Royal London Hospital, Barts Health NHS Foundation Trust
    Feb 17, 2022